We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hands Dr. Reddy’s Untitled Letter for Minimizing Drug Risk
FDA Hands Dr. Reddy’s Untitled Letter for Minimizing Drug Risk
January 17, 2012
Dr. Reddy’s Laboratories’ failure to prominently display a boxed warning on its website for injectable anticoagulant fondaparinux sodium has landed the company an untitled letter.